EP Patent

EP4413974A3 — Methods of treating ocular conditions

Assigned to Oyster Point Pharma Inc · Expires 2024-10-09 · 2y expired

What this patent protects

Described herein are methods and pharmaceutical formulations for treating ocular conditions.

USPTO Abstract

Described herein are methods and pharmaceutical formulations for treating ocular conditions.

Drugs covered by this patent

varenicline-tartrate (VARENICLINE TARTRATE)

Patent Metadata

Patent number: EP4413974A3
Jurisdiction: EP
Classification: —
Expires: 2024-10-09
Drug substance claim: No
Drug product claim: No
Assignee: Oyster Point Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.